3peq
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='3peq' size='340' side='right'caption='[[3peq]], [[Resolution|resolution]] 2.40Å' scene=''> | <StructureSection load='3peq' size='340' side='right'caption='[[3peq]], [[Resolution|resolution]] 2.40Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3peq]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3peq]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3PEQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3PEQ FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=3EQ:[(4-{BUTYL[2-METHYL-4-(METHYLSULFANYL)BIPHENYL-3-YL]SULFAMOYL}NAPHTHALEN-1-YL)OXY]ACETIC+ACID'>3EQ</scene>, <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene>, <scene name='pdbligand=JZR:HEXYL+BETA-D-GLUCOPYRANOSIDE'>JZR</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.4Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=3EQ:[(4-{BUTYL[2-METHYL-4-(METHYLSULFANYL)BIPHENYL-3-YL]SULFAMOYL}NAPHTHALEN-1-YL)OXY]ACETIC+ACID'>3EQ</scene>, <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene>, <scene name='pdbligand=JZR:HEXYL+BETA-D-GLUCOPYRANOSIDE'>JZR</scene></td></tr> | |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3peq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3peq OCA], [https://pdbe.org/3peq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3peq RCSB], [https://www.ebi.ac.uk/pdbsum/3peq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3peq ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3peq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3peq OCA], [https://pdbe.org/3peq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3peq RCSB], [https://www.ebi.ac.uk/pdbsum/3peq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3peq ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
- | + | [https://www.uniprot.org/uniprot/PPARD_HUMAN PPARD_HUMAN] Ligand-activated transcription factor. Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Has a preference for poly-unsaturated fatty acids, such as gamma-linoleic acid and eicosapentanoic acid. Once activated by a ligand, the receptor binds to promoter elements of target genes. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the acyl-CoA oxidase gene. Decreases expression of NPC1L1 once activated by a ligand.<ref>PMID:1333051</ref> <ref>PMID:15604518</ref> | |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 26: | Line 26: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Billin | + | [[Category: Billin AN]] |
- | [[Category: Britt | + | [[Category: Britt C]] |
- | [[Category: Evans | + | [[Category: Evans KA]] |
- | [[Category: Jin | + | [[Category: Jin J]] |
- | [[Category: Lambert | + | [[Category: Lambert MH]] |
- | [[Category: Leesnitzer | + | [[Category: Leesnitzer LM]] |
- | [[Category: Merrihew | + | [[Category: Merrihew RV]] |
- | [[Category: Rivero | + | [[Category: Rivero RA]] |
- | [[Category: Shearer | + | [[Category: Shearer BG]] |
- | [[Category: Shi | + | [[Category: Shi D]] |
- | [[Category: Sparks | + | [[Category: Sparks SM]] |
- | [[Category: Way | + | [[Category: Way JM]] |
- | [[Category: Winegar | + | [[Category: Winegar DA]] |
- | [[Category: Wisnoski | + | [[Category: Wisnoski DD]] |
- | + | ||
- | + |
Current revision
PPARd complexed with a phenoxyacetic acid partial agonist
|
Categories: Homo sapiens | Large Structures | Billin AN | Britt C | Evans KA | Jin J | Lambert MH | Leesnitzer LM | Merrihew RV | Rivero RA | Shearer BG | Shi D | Sparks SM | Way JM | Winegar DA | Wisnoski DD